Santhera’s Phase IIb vamorolone for DMD has experts cautious on trustworthiness of BMI-Z score safety data

duchennemusculardystrophy
In a DMD population where there is a risk of decline in function, any improvement is meaningful. Credit: Shutterstock + hafakot.